Skip to content
healthcare.dev

brivaracetam

NDC 50228-557, brivaracetam, tablet, film coated, from ScieGen Pharmaceuticals, Inc..

Product NDC
50228-557
Status
Listed
Labeler
ScieGen Pharmaceuticals, Inc.
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA219952
DEA schedule
CV
Request
curl https://api.healthcare.dev/v1/drugs/ndc/50228-557 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BRIVARACETAM25 mg/1

Pharmacologic classes

Epoxide Hydrolase Inhibitors [MoA]

Package NDCNDC-11Package
50228-557-10502280557101000 TABLET, FILM COATED in 1 BOTTLE (50228-557-10)
50228-557-305022805573030 TABLET, FILM COATED in 1 BOTTLE (50228-557-30)
50228-557-605022805576060 TABLET, FILM COATED in 1 BOTTLE (50228-557-60)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/bdbb6756-654c-46f1-a85c-7d5d1a89685a

Use it

Look up 50228-557 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/50228-557 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 50228-557. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.